[Virus. II. Viral pathology and trachoma].
D000818:Animals; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002642:Chick Embryo; D002693:Chlamydiaceae; D003235:Conjunctivitis, Inclusion / Q000150:complications; D004267:DNA Viruses; D005455:Fluorescent Antibody Technique; D006506:Hepatitis A / Q000150:complications; D006511:Hepatitis B Antigens; D006801:Humans; D007158:Immunologic Techniques; D007635:Keratitis, Dendritic; D008587:Meningitis, Viral / Q000150:complications; D008722:Methods; D008854:Microscopy, Electron; D012328:RNA Viruses; D011817:Rabbits; D012008:Recurrence; D012282:Rickettsia Infections / Q000150:complications; D012293:Rifampin / Q000627:therapeutic use; D013449:Sulfonamides / Q000627:therapeutic use; D014141:Trachoma / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology* / Q000276:immunology / Q000473:pathology / Q000601:surgery; D014777:Virus Diseases / Q000150:complications*
D000900:Anti-Bacterial Agents; D006511:Hepatitis B Antigens; D013449:Sulfonamides; D012293:Rifampin
Virus. II. Pathologie virale et trachome.